LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

Search

Theravance Biopharma Inc

Fechado

17.26 1.59

Visão Geral

Variação de preço das ações

24h

Atual

Mín

16.91

Máximo

17.65

Indicadores-chave

By Trading Economics

Rendimento

-66M

-4.9M

Vendas

-28M

18M

P/E

Médio do Setor

7.426

50.958

EPS

0.01

Margem de lucro

-27.872

Funcionários

90

EBITDA

-24M

-5M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+4.23% upside

Dividendos

By Acuity

Próximos Ganhos

11 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-17M

854M

Abertura anterior

15.67

Fecho anterior

17.26

Theravance Biopharma Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Sobre Theravance Biopharma Inc

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). The company's product includes Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; and TRELEGY for the treatment of COPD and asthma. It has licensing and collaboration agreements with Pfizer Inc. for its preclinical skin-selective pan-JAK inhibitor program, as well as Viatris Inc. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
help-icon Live chat